Squarepoint
ATYR

Squarepoint’s aTyr Pharma ATYR Stock Holding History

Squarepoint’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-124,924
Closed -$90.1K – 5156
2025
Q3 		$90.1K Buy
+124,924
New +$566K ﹤0.01% 4132
2025
Q2 		– Sell
-235,242
Closed -$710K – 5255
2025
Q1 		$710K Buy
235,242
+208,628
+784% +$761K ﹤0.01% 2965
2024
Q4 		$96.3K Buy
26,614
+13,233
+99% +$40.1K ﹤0.01% 4703
2024
Q3 		$23.6K Buy
+13,381
New +$24.3K ﹤0.01% 4014
2024
Q1 		– Sell
-119,450
Closed -$168K – 4831
2023
Q4 		$168K Sell
119,450
-20,540
-15% -$26.3K ﹤0.01% 3657
2023
Q3 		$221K Sell
139,990
-19,369
-12% -$35.8K ﹤0.01% 3353
2023
Q2 		$344K Buy
159,359
+147,185
+1,209% +$321K ﹤0.01% 2881
2023
Q1 		$25.6K Buy
+12,174
New +$26.7K ﹤0.01% 3112
2016
Q3 		– Sell
-886
Closed -$34K – 1300
2016
Q2 		$34K Buy
+886
New +$41.2K ﹤0.01% 1046

Other funds holding ATYR

RA
Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return